Application of Individualized Treatment for CLL: Novel Agents, Combinations, and Sequencing Therapy

Learn from the experts about novel agents combinations and sequencing therapy for individualized treatment of patients with CLL. Read a ClinicalThought commentary authored by expert faculty and download the clinical resource and slides. Listen to a podcast for answers to FAQs asked during the live Webinar.

Share

Program Content

Activities

CLL: Personalizing 1L Tx
My Take on Personalizing First-line Treatment for Patients With CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 22, 2020

Expires: October 21, 2021

Activities

CLL Clinician Resource
Current Treatment Algorithm for CLL and Clinical Trial Spotlight: A Resource for Clinicians
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

Activities

Treating R/R CLL
Considerations in Selecting Therapy for Previously Treated CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

Frontline Therapy for CLL
Optimal Selection of Therapy for Treatment-Naive CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2020

Expires: December 02, 2021

Future Directions in CLL
Near Future Directions: Promising Agents and Combinations Under Investigation
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

<i>EP</i>: Personalized Tx in CLL
ExpressPoints Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

Activities

FAQ: Personalizing CLL Tx
Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 23, 2020

Expires: December 22, 2021

Faculty

cover img faculity

Jeremy S Abramson, MD, MMSc

Director, Center for Lymphoma
Mass General Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Brian T Hill, MD, PhD

Director, Lymphoid Malignancies Program
Staff Physician, Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio

cover img faculity

William G. Wierda, MD, PhD

Associate Professor of Medicine
Department of Leukemia
The University of Texas
M.D. Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca Pharmacyclics AbbVie

Janssen administered by Scientific Affairs

Lilly